logo
Plus   Neg
Share
Email

Stock Alert: Moleculin Biotech Soars 165% On Potential Treatment For COVID-19

Shares of Moleculin Biotech, Inc. (MBRX) surged about 165% on Wednesday morning after the biotechnology company announced a potential treatment for COVID-19.

MBRX is currently trading at $1.49, up $0.9273 or 164.7948%, on the Nasdaq.

The clinical stage pharmaceutical company announced that independent research found 2-deoxy-D-glucose to reduce replication of SARS-CoV-2, the virus that causes COVID-19, by 100% in in vitro testing.

Researchers at the University of Frankfurt disclosed the findings in their article submitted to NatureResearch on March 11, 2020.

The authors reported that inhibiting glycolysis with non-toxic concentrations of 2-DG completely prevented SARS-CoV-2 replication in Caco-2 cells.

"This is the breakthrough we were looking for, only it came from an unexpected source," commented Walter Klemp, Chairman and CEO of Moleculin. "Normally, we wouldn't have access to data like this until it is published, but the willingness of the authors to pre-release this data will help support our development of WP1122 for treating COVID-19."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Facebook said Tuesday that it has helped 4.4 million people register to vote for the upcoming U.S. presidential election on November 3, exceeding the tech giant's goal of helping 4 million voters to register. In June, Facebook said it created a new Voting Information Center to provide users with authoritative information, including how and when to vote. Facebook has launched cloud-streamed games in the Facebook app and on browser, which are playable instantly, with no downloads required. These cloud-streamed games can be played right alongside those playing instant games in HTML5. The access to cloud games on Facebook will roll out in the US, initially across California, Texas and Northeast and Mid-Atlantic states. Microsoft Corp. has joined with Adobe Inc. and enterprise AI software provider C3.ai to launch a new tool that would help customers to accurately forecast revenue and product demand, among other things. The C3 AI CRM powered by Microsoft Dynamics 365 would provide an integrated suite of industry-specific AI-enabled CRM solutions including marketing, sales, and customer service.
RELATED NEWS
Follow RTT